Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-19,271
Closed -$168K 771
2025
Q1
$168K Sell
19,271
-6,939
-26% -$72.8K 0.01% 670
2024
Q4
$326K Sell
26,210
-347
-1% -$4.26K 0.02% 444
2024
Q3
$308K Sell
26,557
-103
-0.4% -$1.19K 0.02% 439
2024
Q2
$283K Sell
26,660
-15,313
-36% -$169K 0.02% 434
2024
Q1
$501K Sell
41,973
-561
-1% -$6.76K 0.04% 357
2023
Q4
$508K Buy
42,534
+102
+0.2% +$977 0.05% 343
2023
Q3
$384K Buy
42,432
+1,177
+3% +$12.3K 0.04% 353
2023
Q2
$460K Buy
41,255
+21,005
+104% +$201K 0.05% 317
2023
Q1
$195K Buy
20,250
+2,888
+17% +$32K 0.02% 463
2022
Q4
$193K Buy
+17,362
New +$181K 0.02% 454

Other funds holding VTRS

Ascent Group's VTRS Position: Q2 2025 in Review

Ascent Group sold out of Viatris (VTRS) in Q2 2025, closing a stake of 19,271 shares — an estimated $168K sold.

Ascent Group first reported a position in VTRS in Q4 2022 and held it in 10 quarters. The position peaked at $508K in Q4 2023. 975 funds tracked by Wall St. Rank hold VTRS as of Q2 2025.

  • Ascent Group reported no remaining Viatris position as of Q2 2025 after selling out during the quarter.
  • Ascent Group sold 19,271 Viatris shares in Q2 2025, an estimated $168K.
  • Ascent Group first reported a position in Viatris in Q4 2022 and held it in 10 quarters.
  • Ascent Group's Viatris position peaked at $508K in Q4 2023.
  • 975 funds tracked by Wall St. Rank held Viatris as of Q2 2025.

Based on Ascent Group's 13F filing for Q2 2025, filed 21 Jul 2025.